Related Experiment Video

Updated: Aug 6, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Inflammatory bowel disease in childhood--treatment and follow up

C Krebs, H H Nixon

    Zeitschrift Fur Kinderchirurgie : Organ Der Deutschen, Der Schweizerischen Und Der Osterreichischen Gesellschaft Fur Kinderchirurgie = Surgery in Infancy and Childhood
    |February 1, 1984
    PubMed

    Insights

    Pediatric inflammatory bowel disease (IBD) shows Crohn's disease recurs faster than ulcerative colitis after treatment. Surgery is more likely within five years for Crohn's disease in children.

    Area of Science:

    • Pediatric Gastroenterology
    • Inflammatory Bowel Disease Research
    • Clinical Epidemiology

    Background:

    • Inflammatory bowel disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC), often presenting in childhood.
    • Long-term outcomes and recurrence patterns in pediatric IBD require further investigation.
    • Understanding disease trajectories is crucial for effective management strategies.

    Purpose of the Study:

    • To compare the recurrence rates and time to recurrence after medical and surgical treatments for pediatric Crohn's disease and ulcerative colitis.
    • To evaluate the probability of requiring surgery within the initial five years of illness for pediatric CD versus UC.
    • To provide insights into the long-term prognosis of IBD presenting before puberty.

    Main Methods:

    • Retrospective analysis of 150 patients diagnosed with IBD before puberty between 1955 and 1979.
    • Comparison of disease recurrence timelines following medical and surgical interventions.
    • Statistical analysis of the likelihood of early surgical intervention in CD versus UC.

    Main Results:

    • Crohn's disease exhibited a shorter time to recurrence after medical treatment compared to ulcerative colitis (15 months vs. 11 months median relapse time).
    • Pediatric patients with Crohn's disease were twice as likely to require surgery within the first five years compared to those with ulcerative colitis.
    • Median relapse time after surgical treatment was significantly shorter for Crohn's disease (under 5 years) than for ulcerative colitis (over 7 years).

    Conclusions:

    • Crohn's disease in children has a more rapid recurrence pattern post-treatment than ulcerative colitis.
    • Earlier surgical intervention in ulcerative colitis may potentially reduce symptom duration and lower recurrence risk.
    • These findings highlight distinct clinical behaviors of CD and UC in pediatric populations, informing management decisions.

    More Related Videos

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

    Published on: April 6, 2022

    Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis09:44

    Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

    Published on: October 14, 2025

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
    Inflammatory Bowel Disease I: Ulcerative Colitis01:27

    Inflammatory Bowel Disease I: Ulcerative Colitis

    Introduction
    Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
    Risk Factors
    The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
    Inflammatory Bowel Disease II: Crohn's Disease01:30

    Inflammatory Bowel Disease II: Crohn's Disease

    Introduction
    Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
    Crohn's disease
    Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
    Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

    Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

    Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
    Diagnostic studies
    A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
    Inflammatory Bowel Disease IV: Pharmacological Management01:29

    Inflammatory Bowel Disease IV: Pharmacological Management

    Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
    Pharmacologic...
    Inflammatory Bowel Disease V: Surgical Management01:21

    Inflammatory Bowel Disease V: Surgical Management

    Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
    Here are some common surgical interventions for IBD: